Christopher R. Zito, Ph.D.
Affiliations: | 2005 | Wesleyan University, Middletown, CT, United States |
Area:
Molecular Biology, Biochemistry, GeneticsGoogle:
"Christopher Zito"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Donald B. Oliver | grad student | 2005 | Wesleyan | |
| (Study of the regulation of SecA-translocon association and the catalytic role of glutamate-210 in SecA ATPase activity.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Oria VO, Zhang H, Zito CR, et al. (2022) Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma. Cellular and Molecular Life Sciences : Cmls. 79: 377 |
| Tran TT, Rane CK, Zito CR, et al. (2021) Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells. Cancers. 13 |
| Tran TT, Gallezot JD, Jilaveanu LB, et al. (2020) [C]Methionine and [C]PBR28 as PET Imaging Tracers to Differentiate Metastatic Tumor Recurrence or Radiation Necrosis. Molecular Imaging. 19: 1536012120968669 |
| Weiss SA, Zito C, Tran T, et al. (2020) Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases. Journal of Neuro-Oncology |
| Oria V, Zhang H, Zhu H, et al. (2020) 19. PLEKHA5 REGULATES TUMOR GROWTH IN METASTATIC MELANOMA Neuro-Oncology Advances. 2: ii3-ii3 |
| Zhang H, Zhu H, Deng G, et al. (2019) PLEKHA5 regulates tumor growth in metastatic melanoma. Cancer |
| Damsky W, Jilaveanu L, Turner N, et al. (2019) B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors. Journal For Immunotherapy of Cancer. 7: 153 |
| Kluger HM, Chiang V, Mahajan A, et al. (2018) Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1800204 |
| Jilaveanu LB, Puligandla M, Weiss SA, et al. (2017) Tumor microvessel density as a prognostic marker in high-risk renal cell carcinoma patients treated on ECOG-ACRIN E2805. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Kluger HM, Zito CR, Turcu G, et al. (2017) PD-L1 Studies Across Tumor Types, its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |